Meta tags:

Headings (most frequently used words):

crl, flow, cytometry, course, our, mission, success, story, facilities, yervoy, ipilimumab, support, the, newsview, all, news, glp, slows, aging, fall, 2026, world, 1st, ever, accredited, academic, 3rd, successive, year, 2nd, annual, hi, facs, conference,

Text of the page (most frequently used words):
the (25), berkeley (15), cancer (11), research (10), and (10), crl (7), news (6), facility (6), for (5), our (5), 2026 (4), contact (4), flow (4), cytometry (4), full (4), article (4), 2025 (4), lab (4), that (4), breakthrough (4), support (4), story (4), all (3), discoveries (3), 2nd (3), this (3), facilities (3), here (3), has (3), novel (3), was (3), allison (3), yervoy (3), ipilimumab (3), publications (3), mic (3), 510 (2), 642 (2), laboratory (2), life (2), donate (2), gene (2), targeting (2), molecular (2), imaging (2), center (2), core (2), back (2), annual (2), facs (2), conference (2), drop (2), cell (2), nobel (2), fall (2), who (2), have (2), world (2), course (2), year (2), glp (2), researchers (2), access (2), technology (2), their (2), fundamental (2), been (2), approach (2), called (2), work (2), drug (2), jim (2), mission (2), faq (2), fees (2), fcf (2), staff (2), rights, reserved, follow, twitter, edu, 4711, 5741, 449, sciences, addition, university, california, 94720, home, top, tweets, crlberkeley, thrilled, announce, oct, laborat, october, 13th, excites, emits, tale, congratulations, dear, students, succ, 1st, ever, accredited, academic, 3rd, successive, december, 8th, please, register, june, 5th, chen, discovered, late, activation, improved, physiological, function, markedly, extended, slows, aging, september, view, provides, cutting, edge, makes, possible, three, separate, click, ways, because, significant, funding, cuts, national, institutes, health, increasingly, difficult, pay, necessary, next, read, more, one, major, successes, development, treatment, checkpoint, blockade, innovated, prof, james, just, announced, 2013, science, magazine, led, fda, approval, others, like, pipeline, changed, face, therapy, started, success, former, director, shared, 2018, prize, his, immunotherapy, done, 1990s, congrats, see, below, founded, 1951, since, then, campus, goal, provide, class, scientists, with, resources, will, help, them, ambitious, quest, develop, therapeutic, approaches, members, information, training, instrumentation, online, scheduling, acknowledging, meetings, short, courses, education, microscopy, background, getting, trained, equipment, microscopes, workstations, services, gtf, are,

Text of the page (random words):
uc berkeley cancer research lab donate who we are news gene targeting facility gtf publications services fees faq staff and contact molecular imaging center equipment microscopes workstations getting trained education microscopy background mic meetings short courses mic publications acknowledging the mic staff and contact flow cytometry facility fcf facility news fcf publications online scheduling and access to the facility instrumentation fees faq training members and contact information discoveries our discoveries the story of yervoy ipilimumab our mission the uc berkeley cancer research laboratory crl was founded in 1951 since then our mission has been to support fundamental cancer research on the uc berkeley campus our goal is to provide world class scientists at berkeley with resources and facilities that will help them in their ambitious quest to develop novel therapeutic approaches to cancer jim allison former director of the uc berkeley cancer research lab has shared the 2018 nobel prize for his work on immunotherapy done at berkeley in the 1990s congrats jim see the back story below and the uc berkeley news story here success story yervoy ipilimumab one of our major successes has been the development of a novel approach to cancer treatment called checkpoint blockade this novel approach was innovated at berkeley in the cancer research lab by prof james p allison and was just announced as the breakthrough of the year 2013 by science magazine dr allison s work led to fda approval of a breakthrough drug for cancer called yervoy ipilimumab this drug and others like it in the pipeline have changed the face of cancer therapy and it all started here at berkeley in the crl read more support the crl because of significant funding cuts at the national institutes of health it is increasingly difficult for researchers to pay for the fundamental research that is necessary to research the next breakthrough click here for ways to support the crl facilities the crl provides berkeley researchers access to cutting edge technology that makes their breakthrough research possible we support this technology in three separate core facilities crl news view all news september 2nd 2026 glp 1 slows aging the chen lab at uc berkeley discovered that late life glp 1r activation improved physiological function and markedly extended full article june 5th 2026 flow cytometry course fall 2026 please register full article december 8th 2025 world s 1st ever accredited academic flow cytometry course 3rd successive year drop by drop cell by cell excites emits nobel tale fall 2025 congratulations to my dear students who have succ full article october 13th 2025 2nd annual hi d facs conference i am thrilled to announce the 2nd annual hi d facs conference oct 22 23 2025 cancer research laborat full article tweets by crlberkeley back to top home discoveries flow cytometry core facility molecular imaging center gene targeting facility news donate contact cancer research laboratory 449 life sciences addition university of california berkeley berkeley ca 94720 t 510 642 4711 f 510 642 5741 crl berkeley edu follow us on twitter 2026 uc berkeley all rights reserved